State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, 510060, China.
BMC Ophthalmol. 2023 Jan 23;23(1):30. doi: 10.1186/s12886-023-02787-7.
Techniques used to suture the rectus muscle to the implant can influence the implant-related complications which is still a major problem following retinoblastoma enucleation. The goals of this work were to report the efficacy among patients with retinoblastoma who underwent enucleation followed by porous implant placement with the rectus muscles sutured with 5-0 polyester suture.
This was a retrospective study of consecutive patients with retinoblastoma who underwent primary enucleation and porous implant placement with the rectus muscles tagged and sutured to the implant with polyester 5-0 suture. All the patients were followed up for a minimum of 2 years. The main outcome measure was implant exposure. The secondary efficacy measures were other implant-related complications.
Between May 2016 and December 2018, a total of 120 patients (120 eyes) underwent primary enucleation and porous implant placement were included. Postoperatively, 10/120 (8.3%) eyes developed exposure or conjunctival granuloma. Exposure was the most common postoperative complication (7/10, 70.0%). There were no cases of implant extrusion, migration, or infection.
Polyester 5-0 sutures are successful in patients with retinoblastoma who underwent enucleation followed by porous implant placement. Complications are minimal. Polyester 5-0 sutures were not associated with unacceptable complications in this pediatric population.
用于将直肌缝合到植入物上的技术会影响与植入物相关的并发症,这仍然是眼癌患者眼球摘除术后的一个主要问题。本研究的目的是报告眼癌患者接受眼球摘除术和多孔植入物放置后,使用 5-0 聚脂缝线将直肌缝合到植入物上的效果。
这是一项连续接受眼癌患者的回顾性研究,这些患者接受了原发性眼球摘除术和多孔植入物放置,将直肌标记并用 5-0 聚脂缝线固定到植入物上。所有患者均随访至少 2 年。主要观察指标为植入物暴露。次要疗效指标为其他与植入物相关的并发症。
2016 年 5 月至 2018 年 12 月,共纳入 120 例(120 只眼)接受原发性眼球摘除和多孔植入物放置的患者。术后,10/120(8.3%)只眼发生暴露或结膜肉芽肿。暴露是最常见的术后并发症(7/10,70.0%)。无植入物脱出、迁移或感染病例。
在接受眼球摘除和多孔植入物放置的眼癌患者中,5-0 聚脂缝线是成功的。并发症很少。在该儿科人群中,5-0 聚脂缝线与不可接受的并发症无关。